Tag: pulmonary embolism
AVF 2023: FLASH registry suggests “favourable safety and effectiveness profile” in...
Among 61 high-risk pulmonary embolism (PE) patients followed through to the 30-day visit in the US cohort of the FLASH registry, no mortalities were...
Viz.ai to expedite patient enrolment in NIH-funded PE-TRACT clinical trial
Viz.ai has announced it will use its Viz Recruit platform to optimise patient enrolment for the National Institutes of Health (NIH)-funded Pulmonary embolism—thrombus removal...
New study demonstrates IVC filters “safe and effective” in treating venous...
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
Inari Medical announces first patient enrolment in DEFIANCE trial of the...
Inari Medical has announced that the first patient has been enrolled in DEFIANCE, a prospective randomised controlled trial (RCT) comparing the clinical outcomes of...
FLASH results demonstrate “excellent safety profile” of the FlowTriever system in...
Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 “real-world” patients. This is according to...
Penumbra and Asahi Intecc partner to introduce Indigo system to Japan
Penumbra and Asahi Intecc, a Japanese medical device manufacturer, announced that they will collaborate to introduce Penumbra’s Indigo aspiration system into the Japanese market...
RESCUE trial of the Bashir endovascular catheter demonstrates reduction in pulmonary...
Thrombolex today presented the final results of its National Institutes of Health (NIH)-sponsored RESCUE trial at TCT 2022 (16–19 September, Boston, USA).
This investigational...
Viz.ai receives FDA 510(k) clearance for automated RV/LV analysis algorithm
Viz.ai recently announced it has received US Food and Drug Administration (FDA) 510(k) clearance for an automated right ventricle (RV)/left ventricle (LV) ratio algorithm,...
New data underscore benefits of Penumbra’s Indigo for submassive pulmonary embolisms...
In a new subgroup analysis of the EXTRACT-PE trial, the Indigo aspiration system (Penumbra) was effective at improving clinical outcomes for submassive pulmonary embolism...
RapidAI receives FDA 510(k) clearance for PE Triage & Notification
RapidAI announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for its Rapid PE Triage & Notification product for...
Magneto Thrombectomy Solutions announces successful first-in-human results for treatment of pulmonary...
Magneto Thrombectomy Solutions (Magneto), a medical devices company developing thrombectomy solutions for the treatment of ischaemic stroke and pulmonary embolism, presented successful first-in-human (FIH)...
Penumbra announces the European launch of the Indigo system with Lightning...
Penumbra has announced that its Indigo aspiration system with Lightning 7 and Lightning 12 have secured CE mark and are now commercially available in...
Study finds increased risk of serious blood clots up to six...
A study from Sweden published by The BMJ recently finds an increased risk of deep vein thrombosis (DVT) up to three months after COVID-19 infection,...
Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...
Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...
Anticoagulants effective for pulmonary embolism resolution in hospitalised COVID-19 patients
Anticoagulants alone are associated with a high rate of resolution of pulmonary embolism (PE) in patients with acute PE and COVID-19 infection. This was...
First patient enrolled in PEERLESS study of FlowTriever system
Inari Medical has announced that the first patient has been enrolled in PEERLESS—a prospective, randomised controlled trial (RCT) comparing the outcomes of patients with...
Thrombolex announces new interim data from RESCUE trial of the Bashir...
Thrombolex has announced positive results from the prespecified interim analysis of the first 62 evaluable pulmonary embolism (PE) patients enrolled in the investigational RESCUE...
Viz.ai launches two new AI-powered modules for pulmonary embolism and aortic...
Viz.ai has announced the US commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at VEITHsymposium 2021 (16–20 November, Orlando, USA), the...
Inari Medical announces six-month FLASH registry interim data
Inari Medical has announced positive acute and long-term interim results from the first 500 pulmonary embolism (PE) patients enrolled in the FlowTriever outcomes registry...
Positive data for the EkoSonic endovascular system presented at VIVA 2021
Boston Scientific announced positive results for the EkoSonic endovascular system (EKOS system) during a late-breaking clinical trial presentation at Vascular Interventional Advances (VIVA) 2021...
Thrombolex announces interim RESCUE results at VIVA 2021
Thrombolex recently announced the results of the RESCUE trial’s prespecified interim analysis, of the first 62 evaluable patients, in a late-breaking clinical trials session...
Inari Medical appoints pulmonologist Victor F Tapson as VP of Medical...
Inari Medical has announced that the company has appointed Victor F Tapson as vice president of Medical Affairs.
Tapson has devoted his medical career to...
Thromboprophylaxis with anticoagulants “likely effective” at preventing VTE post-vascular surgery, larger...
“Among patients undergoing vascular surgery, thromboprophylaxis with anticoagulants showed a trend towards reduced incidence of VTE when compared to placebo,” Tarek Haykal (Duke...
Boston Scientific initiates randomised controlled trial for the EkoSonic endovascular system
Boston Scientific has commenced enrolment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the...
Viz.ai and Avicenna.AI partner to launch AI-driven intelligent care coordination for...
Viz.ai has partnered with Avicenna.AI to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease.
Avicenna.AI’s US...
Thrombolex receives enhanced indication for use from the FDA
The US Food and Drug Administration (FDA) has enhanced the indications for use of the Bashir endovascular catheter (Thrombolex) and the Bashir Plus endovascular...
Propofol use during catheter-directed interventions for intermediate-risk PE associated with major...
A study suggests avoiding propofol for intraprocedural sedation during catheter-directed interventions (CDIs) for intermediate-risk pulmonary embolism (PE) because it can have detrimental effects. Propofol...
AI triage solution for PE and aortic dissection receives FDA clearance...
Medical imaging artificial intelligence (AI) specialist Avicenna.AI recently announced that it has received certification in the USA and European Union (EU) for CINA CHEST,...
Meta-analysis: IVC filters should be considered for certain patients at high...
In a recent meta-analysis, Yang Liu, Huan Lu (Henan Cancer Hospital, Zhengzhou, China), and colleagues found insufficient evidence to prove that inferior vena cava...
First-in-human results for the Bashir endovascular catheter published
Results of a first-in-human study to assess the safety and feasibility of the Bashir endovascular catheter (Thrombolex) for the treatment of acute intermediate-risk pulmonary...
Aidoc and Imbio partner to provide an AI solution to prioritise...
Aidoc and Imbio have announced a partnership intended to provide an end-to-end artificial intelligence (AI) solution for pulmonary embolism (PE), with the goal of ultimately...
Penumbra’s newest generation of Indigo aspiration system receives FDA clearance for...
Penumbra today announced US Food and Drug Administration (FDA) 510(k) clearance for expanded indication of the latest iteration of the Indigo aspiration system, Lightning...
Inari Medical announces presentation of 30-day follow-up results from first patients...
Inari Medical has announced follow-up results of the first 230 patients enrolled in its FLASH study. FLASH is a real-world registry to study the...
FLASH registry: Interim results “reinforce the excellent FlowTriever safety profile”
Catalin Toma (University of Pittsburgh, Pittsburgh, USA) recently presented interim results from the FLASH registry during a late-breaking session at TCT Connect (14–18 October,...
Systematic review finds high risk of deep vein thrombosis and pulmonary...
In a systematic review of the worldwide published data on venous thromboembolism (VTE) in COVID-19 patients, Cihan Ay, Stephan Nopp, and Florian Moik (Medical...
HOME-PE trial clarifies which patients with acute PE can be managed...
Patients with acute pulmonary embolism (PE) can be selected for home management using the sPESI score or the Hestia criteria, according to results of...
Study finds death rates from PE have been rising over the...
The American Heart Association (AHA) has announced that after nearly a decade of steady decline, the death rate for people with pulmonary embolism (PE)...
First patient enrolled in RESCUE trial of Thrombolex’s Bashir catheter
Thrombolex has announced that it has enrolled the first patient in its pivotal RESCUE trial for the treatment of patients with acute submassive pulmonary...
Compression stockings might not be needed to prevent blood clots after...
Compression stockings might be unnecessary to prevent blood clots in most patients undergoing non-emergency (elective) surgery, finds a clinical trial published by The BMJ...
Elder statesman of venous disease delivers golfing metaphor for fortitude, wellness
As a podium talk at the annual meeting of the American Venous Forum (VENOUS 2020; 3–6 March, Amelia Island, USA), it represented a bit...
First-in-human results for Bashir Endovascular Catheter meet safety and feasibility endpoints
Thrombolex has announced that results of its First-In-Human (FIH) trial confirm the early safety and feasibility of using the Bashir Endovascular Catheter for pharmacomechanical...
No difference in PE incidence between patients treated with IVC filters...
In a case-control study of patients with perceived contraindications to anticoagulation, who either received or did not receive inferior vena cava (IVC) filters, no...
Improved follow-up measures needed to fill knowledge gap in long-term PE...
“We need to check for signs of recurrence and functional impairment, and follow these patients much more closely,” urged Kenneth Rosenfield (Massachusetts General Hospital,...
SUNSET sPE thrombolysis trial completes enrolment phase
The “Standard versus ultrasound-assisted catheter thrombolysis for submassive pulmonary embolism” (SUNSET sPE) trial, a randomised, single-blinded clinical trial comparing ultrasound-assisted thrombolysis (USAT) to standard...
Penumbra wins FDA clearance for Indigo Aspiration System
Penumbra has announced US Food and Drug Administration (FDA) 510(k) clearance for expanded indication of the Indigo Aspiration System. As part of the system,...
First pulmonary embolism patient treated with “cyclical” aspiration system
Insera Therapeutics’ CLEAR aspiration system has been used for the first time to treat a (human) patient with acute pulmonary embolism (PE). CLEAR, “cyclical...
FDA approves first generics of Eliquis for prophylaxis of DVT and...
The US Food and Drug Administration (FDA) has announced the approval of two applications for the first generics of Eliquis (apixaban) tablets, to reduce...
Insera announces first-in-human treatment of patient with PE using CLEAR aspiration...
Insera Therapeutics announced recently that the first patient with acute pulmonary embolism has been treated with its flagship cyclical aspiration system, CLEAR. Earlier last...
New trial planned to rigorously test catheter-directed thrombolysis for submassive PE...
Clinically relevant outcomes are needed to measure catheter-directed therapy (CDT) against anticoagulation alone to treat submassive pulmonary embolism (PE) patients. Further, CDT’s ability to...
EXTRACT-PE trial of aspiration thrombectomy for acute pulmonary embolism meets efficacy...
It has been found by the EXTRACT-PE trial, a multicentre investigation conducted under an investigational device exemption (IDE) from the US Food and Drug...
Thrombolex announces first enrolment in early feasibility and safety study using...
Thrombolex has announced the enrolment of the first patient in their Early Feasibility and Safety Study, investigating the Bashir Endovascular Catheter for the treatment...
Catheter-directed thrombolysis treatment for PE may significantly reduce long-term costs with...
Catheter-directed thrombolysis improves outcomes and long-term cost efficiency for treatment of massive and submassive pulmonary embolism (PE), in comparison to systemic heparin administration. This...
SUNSET sPE thrombolysis trial presents interim analysis of ultrasound-guided versus standard...
The Standard vs ultrasound-assisted catheter thrombolysis for submassive pulmonary embolism (SUNSET sPE) trial, is an ongoing randomised, head-to-head, single-blinded clinical trial comparing ultrasound-assisted thrombolysis...
Inari Medical announces publication of FLARE IDE study results
Inari Medical has announced the publication of its 106-patient prospective multicentre FlowTriever Mechanical Pulmonary Embolectomy (FLARE) study for the treatment of intermediate-risk pulmonary embolism...
BTG acquires Novate Medical
BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...
Study proves need for anticoagulant strategy post discharge for hospitalised, at-risk...
Alex C Spyropoulos, from Feinstein Institute for Medical Research (New York, USA), has presented an anticoagulant treatment strategy to reduce non-fatal blood clots and...
PERT Consortium and BTG form strategic partnership
BTG has announced a strategic partnership with the PERT Consortium to advance the science of pulmonary embolism treatment and promote the implementation of PERT...
Direct anticoagulant for pulmonary embolism associated with reduced hospital time and...
New data from the MERCURY PE study have shown that patients with low-risk pulmonary embolism who were treated with the direct oral anticoagulant rivaroxaban,...
Cancer-associated VTE trial sees “lower rate of recurrent VTE with edoxaban...
Daiichi Sanyoko has announced the results from their Hokusai-VTE CANCER trial evaluating the direct oral anticoagulant edoxaban for treatment of venous thromboembolism (VTE) in...
Study to measure shorter duration EKOS therapy for pulmonary embolism is...
Global specialist healthcare company BTG has highlighted the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how hospitals and patients...
Inari Medical announces completion of enrolment in the FLARE study for...
Inari Medical has announced that it has completed enrolment of its investigational device exemption (IDE) study. The FlowTriever Pulmonary Embolectomy Clinical Study (FLARE) study...
One-year SENTRY trial data offer a “a new perspective” on IVC...
Twelve-month results from the SENTRY trial evaluating the Sentry bioconvertible inferior vena cava (IVC) filter (Novate) have shown a 0% rate of symptomatic pulmonary...
Angel Catheter demonstrates reduction in clinically-significant and fatal pulmonary embolism
Bio2 Medical has announced the results of the Angel Catheter pivotal study published in the Journal of Vascular and Interventional Radiology. The Angel Catheter...
ACCESS PTS study demonstrates efficacy of EKOS therapy for post-thrombotic syndrome
The results of the ACCESS PTS trial have been presented at the Society for Vascular Medicine 28th Annual Scientific Sessions (14–17 June, New Orleans,...
OPTALYSE PE study demonstrates safety and efficacy of shorter, lower dose...
Results from the OPTALYSE PE trial have been presented at the American Thoracic Society International Conference in Washington, DC, USA. The results show that...
High-risk pulmonary embolism patients often go without most effective treatments
In a new study presented at the American College of Cardiology 66th Annual Scientific Session, researchers from the Perelman School of Medicine at the University of...